Access the full text.
Sign up today, get DeepDyve free for 14 days.
References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.
Abstract Not infrequently during or after arsphenamine therapy, visible jaundice develops rather suddenly in certain patients and within from a few days to several weeks terminates in clinical recovery. Because of the benign course of this jaundice, material for gross and histologic examination is practically unavailable. Most discussions, therefore, dealing with the etiology and morbid anatomy of the condition have been characterized by inferences drawn from clinical observations rather than by conclusions founded on pathologic data. We report the following two cases of nonfatal jaundice associated chronologically with arsphenamine therapy because in each instance we had the unusual opportunity of making adequate histologic studies of the liver. In case 1 the patient died from a bleeding peptic ulcer and ascending pyelonephritis four weeks after jaundice had disappeared from the skin and scleras. In case 2 material for biopsy of the liver was obtained during the height of icterus at laparotomy performed
Archives of Dermatology and Syphilology – American Medical Association
Published: Nov 1, 1935
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.